Tag: nicotinamide mononucleotide

Stimulation of Nicotinamide Adenine Dinucleotide Biosynthetic Pathways Delays Axonal Degeneration After Axotomy

This 2006 study investigates the role of NAD⁺ biosynthesis in axonal protection following injury. Researchers overexpressed various NAD⁺ biosynthetic enzymes and administered their respective substrates in cultured dorsal root ganglion (DRG) neurons. Among the enzymes tested, NMNAT1 exhibited the strongest protective effect against axonal degeneration, while NMNAT3 and a cytoplasm-localized

Read More »

NAD+ in Aging: Molecular Mechanisms and Translational Implications

This 2017 review explores the critical role of nicotinamide adenine dinucleotide (NAD⁺) in aging and age-related diseases. NAD⁺ is essential for cellular metabolism, DNA repair, and stress responses. The study highlights that NAD⁺ levels decline with age, contributing to various pathologies, including neurodegenerative diseases, cardiovascular conditions, and muscle atrophy. The

Read More »

Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors

This 2021 review examines the pharmacological properties and therapeutic potential of NAD⁺ precursors, including nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and nicotinic acid (NA). The authors discuss how these compounds enhance NAD⁺ levels, influencing cellular redox states, energy metabolism, and sirtuin activity. The review highlights the role of NAD⁺ in

Read More »

The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential

This 2021 review explores the multifaceted role of nicotinamide adenine dinucleotide (NAD⁺) in cardiovascular diseases (CVDs). NAD⁺ is integral to metabolic pathways, redox balance, and immune modulation. The article discusses how NAD⁺ influences cardiovascular health through sirtuin-dependent and independent mechanisms, affecting aging, inflammation, and oxidative stress. It highlights the potential

Read More »

Nicotinamide Mononucleotide Ameliorates Senescence in Alveolar Epithelial Cells

This study investigates the effects of nicotinamide mononucleotide (NMN) on alveolar epithelial cell (AEC) senescence. NMN supplementation in aged C57BL/6 mice (8–10 months old) and in a bleomycin-induced pulmonary fibrosis model in young mice (6–8 weeks old) demonstrated significant mitigation of age-associated physiological decline in the lungs. In vitro, NMN

Read More »